broad · 2020-08-06 · extended antiobiotic 200 release broad spectrum coverage - the first...
TRANSCRIPT
EXTENDED ANTIOBIOTIC RELEASE
BROAD SPECTRUM COVERAGE
- The first Gentamicin + Vancomycin hip spacer and bone cement available in the U.S.
- Increased spectrum of coverage to include MRSA/MRSE 1,2
- Synergistic antimicrobial efficacy against gram (+) pathogens3,4
- REMEDY SPECTRUM® GV Hip elution extends beyond 28 days5 while intra-operative mold elution was undetectable after 14 hours6
SPECTRUM® GV HIP SPACER
The REMEDY SPECTRUM® GV Hip is 95.5% Clinically Effective, defined as the absence of 2 or more positive cultures at the time of reimplantation.5
PROVEN CLINICALLY EFFECTIVE
2
Days
0 2 4 6 8
Cummulative Antibiotic Release - Comparison
10 12 14 16 18 20 22 24 26 28
250
200
150
100
50
0
Elu
tio
n A
mo
un
t (m
g)
REMEDY SPECTRUM GV Hip Long(2.4g Vancomycin & 2.4g Gentamicin Per Construct)
REMEDY SPECTRUM GV Hip Short(2.2g Vancomycin & 2.2g Gentamicin Per Construct)
225.4
161.4
29.523.013.1
Intraoperative Molds(3.6g Tobramycin & 1g Vancomycin Per Construct)
6
REMEDY SPECTRUM GV Hip w/Medium Long Stem (54mm Head)
REMEDY SPECTRUM GV Hip w/Medium Short Stem (54mm Head)
Prostalac: Large Stem
Prostalac: Medium Stem
Prostalac: Small Stem
REMEDY SPECTRUM GV Hip Spacers tested in Lab A while Prostalac Spacers were tested in Lab B
Source: Prostalac HDE H000004
®
®
®
®
®
93% of the GV subjects were finished with their antibiotic course within a week.5
SYSTEMIC ANTIBIOTIC USAGE 0 - <7
REMEDY SPECTRUM GV Spacer* 93% (39) 0% (0) 2% (1) 2% (1) 2% (1) 42
Duration of Antibiotic Usage After Reimplantation (Days)
7 - <14 14 - <30 30 - <90 >365 Total
HIP SUBJECTSN n %
REMEDY SPECTRUM GV Spacer 22 21 95.5%
Success at Stage 2
®
®
SYSTEMIC ANTIBIOTIC USAGE 0 - <7
REMEDY SPECTRUM GV Spacer* 93% (39) 0% (0) 2% (1) 2% (1) 2% (1) 42
Duration of Antibiotic Usage After Reimplantation (Days)
7 - <14 14 - <30 30 - <90 >365 Total
HIP SUBJECTSN n %
REMEDY SPECTRUM GV Spacer 22 21 95.5%
Success at Stage 2
®
®
Spectrum Of Activity Of Vancomycin & Gentamicin
Pseudomonas spp.
Enterobacteriaceae
Streptococcus spp.
Enterococcus spp.
Staphylococcus spp.(Methicillin-resistant) MRSA/MRSE
Staphylococcus spp.(Methicillin-sensitive)
5
REMEDY® & REMEDY SPECTRUM® GV HIP SPACER TECHNIQUE
Note: For additional fixation to the stem the remaining offset space and threads of the stem, up to the femoral head, can be filled with antibiotic-loaded bone cement. Cement may also be applied once seated within the femoral canal.
STEP 1In accordance with the existing total joint manufacturer’s technique, prepare the infected joint space by first removing the prosthesis and any PMMA cement, if present, and any hardware (which may be a reservoir of infection).
STEP 7Remove the cover cap, pour the remaining monomer out and place head onto the femoral stem. Begin to turn the femoral head until the appropriate off-set is achieved.
WARNING: The head must be seated past the safety colored line marked on the stem thread.
On the trials, the colored line is designated with a missing thread on the stem neck.
Important Note: Once the head location is selected be sure not to continue to adjust the head location as this could affect the fixation between the head and the stem.
STEP 3Using UNITE® AB Bone Cement, or any FDA-cleared gentamicin-based PMMA, apply cement to the native acetabulum and the backside of the REMEDY® Acetabular Cup. Place the acetabular cup into the acetabulum by hand.
STEP 2Using the REMEDY® Spacer Trials,† select the appropriate size femoral stem, femoral head, and acetabular cup (if applicable).†† If using the acetabular cup, check the dimensions of the native acetabulum using the TRIAL end of the REMEDY® Acetabular Cup Trial/Handle.
If implanting without an acetabular cup, proceed to Step 6.
TRIALS
STEP 5With the acetabular cup in place, a final trial reduction may be performed using the trial stem and head components to confirm or correct implant positioning, noting the chosen off-set with the head seated past the missing thread on the stem neck.
COVER CAP
With the appropriate head size selected, open the packages and remove the monomer vial.
STEP 6
Insert and seal the hole with the plastic cover cap supplied. Shake the head for 60 seconds to ensure all of the threads within the head are wet with monomer.
Break the vial open and pour all the monomer into the screw opening of the head.
STEP 4Using the IMPLANT end of the REMEDY® Acetabular Cup Trial/Handle, position the cup spacer into the desired orientation within the native acetabulum.
Note: When placing the components with cement, do not impact with a mallet. It is recommended to use the trial/handle with hand pressure only.
STEP 9Insert the stem (with head properly affixed) into the canal. Perform a final reduction to assess joint stability and implant align-ment.
Note for spacer removal: Prior to implantation of a new permanent THR, the operative area should be rigorously irrigated and rinsed after device extraction to remove all cement debris prior to implantation of the permanent prosthesis or other surgical procedures (e.g., resection arthroplasty, etc.).
† The REMEDY® SPACER TRIALS can be used with the REMEDY® & REMEDY SPECTRUM® GV Hip Spacers.
†† The SPECTRUM ® GV Bone Cement is indicated for the fixation of a REMEDY SPECTRUM® GV Hip Spacer to the host bone.
GV HIP SPECIFICATIONS
STEP 8Using UNITE® AB Bone Cement, or SPECTRUM® GV Bone Cement, apply cement to the proximal aspect of the stem.†† The use of the cement is compulsory to avoid rotation and to limit the risk of dislocation.
HIP COMPONENT DESCRIPTION
REMEDY SPECTRUM GV Modular Femoral Head – 40 mm
REMEDY SPECTRUM GV Modular Femoral Head – 46 mm
REMEDY SPECTRUM GV Modular Femoral Head – 54 mm
REMEDY SPECTRUM GV Modular Femoral Head – 60 mm
REMEDY SPECTRUM GV Modular Femoral Stem - Small
REMEDY SPECTRUM GV Modular Femoral Stem - Medium
REMEDY SPECTRUM GV Modular Femoral Stem - Large
REMEDY SPECTRUM GV Modular Femoral Long Stem - Small
REMEDY SPECTRUM GV Modular Femoral Long Stem - Medium
REMEDY SPECTRUM GV Modular Femoral Long Stem - Large
GVHDXS
GVHDSM
GVHDMD
GVHDLG
GVSTSM
GVSTMD
GVSTLG
GVLSSM
GVLSMD
GVLSLG
® .46
0.9
1.6
2.3
0.5
0.6
0.7
0.6
0.8
0.9
.46
0.9
1.6
2.3
0.5
0.6
0.7
0.6
0.8
0.9
.92
1.8
3.2
4.6
1.0
1.2
1.4
1.2
1.6
1.8
®
®
®
®
®
®
®
®
Catalog # GentamicinBase (g)
VancomycinBase (g)
Total GV (g)
3
1-800-OSTEO-XL 901-453-3141 [email protected] OsteoRemedies.com
OsteoRemedies, LLC 6800 Poplar Avenue Suite 120 Memphis, TN 38138
SPECTRUM® GV BONE CEMENT
Palacos is a registered trademark of Heraeus Kulezr GmbH. Prostalac is a registered trademark of DePuy Synthes.REMEDY SPECTRUM, SPECTRUM, OsteoRemedies and the corporate mark are trademarks of OsteoRemedies, LLC • REMEDY and SPECTRUM are manufactured by OsteoRemedies, LLC
©2020 • MKT002 • 7-20-V4
POWERFUL COMBINATION, RELIABLE PERFORMANCE
Powerful:- 4X the antibiotic content compared to Palacos® R+G
- Dual Antibiotic Spectrum includes Gram (+) and Gram (-) Pathogens
Reliable:- Mechanical Performance comparable to Palacos® R+G
- Exceeded Required ISO Bone Cement Standards
1 Minelli, E. Bertazzoni, et al., 2011. Anaerobe 17(6), 380-383.2 Trampuz, A., et. al., 2005. Swiss Med Weekly. 135(17-18): 243-51. Review.3 Watanakunakom, et al., 1980 Journal of Antimicrobial Chemotherapy 6, 785-791.4 Watanakunakom, et al., 1982. Antimicrobial Agents and Chemotherapy, 903-905.5 For complete data and associated risks reference the REMEDY SPECTRUM® GV Hip IFU. In a review of 22 patients, clinical effectiveness was defined as the absence of 2 or more positive cultures at the time of reimplanation. Patients should be monitored for ototoxicity and nephrotoxicity while under- going treatment for PJI.6 Prostalac HDE H000004 Data.7 Bishop, A., et al., 2018. Data in Brief. 20. 14-19.8 Carann, R. et al., 2013. World Journal of Orthopaedics. 9327(36).
0 1 2 3 4 5 6 7 9 10 11 12 13
Tem
pe
ratu
re (
°C)
Tem
pe
ratu
re (
°F)
Setting Time (Min)
30
29
28
27
26
25
24
23
22
21
20
19
18
17
16
15
86.0
84.2
82.4
80.6
78.8
77.0
75.2
73.4
71.6
69.8
68.0
66.2
64.4
62.6
60.8
59.0
14 15 16 17 18 19 20
TOLERANCE -
TOLERANCE +
NORMAL RELATIONSHIP
SPECTRUM® GV Bone Cement is indicated for use only with REMEDY SPECTRUM® GV Hip Spacer
40g Bag 1g 1g 2g
2.5% 2.5% 5%
Gentamicin BaseCatalog #
SPECTRUM40Spectrum GVBone Cement
Vancomycin Base Total
®
3500
3000
2500
2000
1500
1000
500
0
Be
nd
ing
Mo
du
lus
(MP
a)
SPECTRUM® GV 2g
Palacos®R+G 0.5g
Palacos® 1g Vanc
Palacos® 2g Vanc
70
60
50
40
30
20
10
0
Be
nd
ing
Str
en
gth
(M
Pa)
SPECTRUM®GV 2g
Palacos®R+G 0.5g
Palacos® 1g Vanc
Palacos® 2g Vanc
120
100
80
60
40
20
0Co
mp
ress
ive
Str
en
gth
(M
Pa)
SPECTRUM® GV 2g
Palacos®R+G 0.5g
Palacos® 1g Vanc
Palacos® 2g Vanc
Antibiotic Bone Cement Mechanical Performance ISO Standard5,7,8
SPECTRUM GV Bone Cement was tested in Lab A, Palacos R+G in Lab B, and Palacos 1g Vanc and Palacos 2g Vanc were tested in Lab C® ® ®®
The REMEDY® Hip Trials can be used with
the REMEDY® Hip Spacer and REMEDY SPECTRUM®
GV Hip Spacer.
The REMEDY® and REMEDY SPECTRUM® GV Hip Spacer System Allows
For Modularity Without The Waiting
t
t
t